Nu-Med Plus (NUMD) Return on Assets Growth (1y) (2014 - 2025)
Nu-Med Plus (NUMD) Return on Assets Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 5.00 |
| Jun 30, 2025 | 2.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | -12.00 |
| Jun 30, 2024 | -10.00 |
| Mar 31, 2024 | -9.00 |
| Dec 31, 2023 | -6.00 |
| Sep 30, 2023 | 406.00 |
| Jun 30, 2023 | 294.00 |
| Mar 31, 2023 | 172.00 |
| Dec 31, 2022 | 76.00 |
| Sep 30, 2022 | -389.00 |
| Jun 30, 2022 | -288.00 |
| Mar 31, 2022 | -169.00 |
| Dec 31, 2021 | -76.00 |
| Sep 30, 2021 | -15.00 |
| Jun 30, 2021 | -5.00 |
| Mar 31, 2021 | 12.00 |